Analyst Viewpoint
Rise in demand for biopharmaceuticals is a dominant factor contributing to the bioprocess analyzers market growth. Increase in geriatric population worldwide, prevalence of chronic diseases, and constant innovations in the healthcare sector are augmenting the demand for biopharmaceuticals such as vaccines, antibiotics, and insulin.
Surge in R&D spending in the biotechnology sector is also propelling the bioprocess analyzers industryt size. Bioprocess analyzers are sensitive and innovative equipment that allow for real-time data collection of crucial parameters such as metabolism rate, cell growth, pH, and final product yield.
These parameters are vital for scaling up research output to large-scale industrial applications for the benefit of public health.
Key players in the global bioprocess analyzers market are developing instruments that are more compact, portable, precise, and efficient, as demand for innovative healthcare solutions rises and leads to lucrative opportunities.
Bioprocess analyzers refer to sophisticated instruments utilized in biopharmaceutical manufacturing processes to monitor and control various parameters such as pH, dissolved oxygen, and nutrient levels.
These devices offer real-time monitoring and data collection that assists in analyzing data precisely and timely to ensure an optimal environment for cell growth, protein or gene expression, and final product yield.
Bioprocess analyzers, including process control instruments and biomass analysis equipment, offer several benefits such as enhanced mechanism efficiency, improved output quality, mitigated risks, and reduced production duration.
Pharmaceutical firms and biotechnology startups invest in bioproduction measurement devices, as they ensure that the product yield meets compliance standards, shortens product cycles, and increases overall productivity.
Recent bioprocess analyzers market trends suggest a gradual shift toward the incorporation of advanced sensors, data analytics, artificial intelligence, and automation. Additionally, compact and portable bioreactor monitoring tools are gaining traction.
Biopharmaceuticals are drugs derived from biological sources, such as living organisms, or their components. These bioactive drugs have several benefits including enhanced specialty and efficacy and reduced risk of side effects compared to conventional medicines that are synthesized via chemicals.
Rise in prevalence of chronic diseases and genetic disorders, consistent advancements in biotechnology, and surge in geriatric population across the globe are some of the factors boosting the demand for biopharmaceuticals such as insulin and vaccines.
As per the World Health Organization (WHO), by 2026, about 40 million to 60 million doses of malaria vaccines are required to combat the disease. These numbers are set to rise to 100 million doses by the year 2030.
Heightened demand for vaccines, insulins, and antibodies is augmenting the bioprocess analyzers market demand.
Prevalence of complex & evolving diseases and rise in demand for advanced healthcare solutions are leading to a surge in R&D spending in the biotechnology sector.
Collaborative and strategic efforts between governments, private players, and academic institutions are offering promising breakthroughs in novel therapies, drugs, and diagnostic systems, thus propelling the bioprocess analyzers market value.
Bioprocess analyzers and allied products are crucial for biotechnology research, as they make precise measurements and collect real-time data about nutrition levels, metabolism rate, cell growth, and product yield.
These specialized devices act as a bridge between the research work and real-life mass application with a focus on regulatory compliance, process optimization, and quality assurance. This is boosting the probability of technology scale-up.
North America held the largest bioprocess analyzers market share in 2022. Increase in adoption of advanced cell culture analysis instruments and rise in healthcare expenditure are augmenting the region's market dynamics.
According to a report by Evaluate Pharma, the top 11 pharma firms globally, which are primarily located in North America, spent more than US$ 104.0 Bn on R&D in 2022. This constituted 42% share of total pharma research spending worldwide.
According to the latest bioprocess analyzers industry analysis, the industry in Asia Pacific is projected to grow at a steady pace from 2023 to 2031. Expansion in biomanufacturing capabilities and high demand for vaccines and antibiotics are propelling the latest bioprocess analyzers market statistics in the region.
India is termed the ‘pharmacy of the world’, with an overall capacity of 8.2 billion doses annually.
Prominent manufacturers in the bioprocess analyzers market are investing significantly in the development of microbial fermentation analyzers and bio-manufacturing analytics systems to offer improved monitoring and control during the pharmaceutical and biotechnology production process.
Nova Biomedical, Sartorius Group, F. Hoffmann-La Roche Ltd., SYSBIOTECH GmbH, Kaiser Optical Systems, Inc., YSI, Inc. (Xylem, Inc.), and Randox Laboratories Ltd. are the leading companies operating in the global landscape.
These companies have been profiled in the bioprocess analyzers market report in terms of parameters such as business strategies, product portfolio, company overview, financial overview, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 1.9 Bn |
| Market Forecast Value in 2031 | US$ 4.0 Bn |
| Growth Rate (CAGR) | 8.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 1.9 Bn in 2022
It is projected to grow at a CAGR of 8.9% from 2023 to 2031
Increase in demand for biopharmaceuticals and surge in R&D in biotechnology
The contract manufacturing organizations segment accounted for the largest share in 2022
North America dominated the global landscape in 2022
Nova Biomedical, Sartorius Group, F. Hoffmann-La Roche Ltd., SYSBIOTECH GmbH, Kaiser Optical Systems, Inc., YSI, Inc. (Xylem, Inc.), and Randox Laboratories Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Bioprocess Analyzers Market
4. Market Overview
4.1. Introduction
4.1.1. Technology, Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Bioprocess Analyzers Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology, /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Bioprocess Analyzers Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Instruments
6.3.2. Consumables & Accessories
6.4. Market Attractiveness Analysis, by Product,
7. Bioprocess Analyzers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Antibiotics
7.3.2. Recombinant Proteins
7.3.3. Biosimilars
7.3.4. Monoclonal Antibodies
7.4. Market Attractiveness Analysis, by Application
8. Bioprocess Analyzers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Biopharmaceutical Companies
8.3.2. Contract Manufacturing Organizations
8.3.3. Contract Research Organizations
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Bioprocess Analyzers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Bioprocess Analyzers Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Instruments
10.3.2. Consumables & Accessories
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Antibiotics
10.4.2. Recombinant Proteins
10.4.3. Biosimilars
10.4.4. Monoclonal Antibodies
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Biopharmaceutical Companies
10.5.2. Contract Manufacturing Organizations
10.5.3. Contract Research Organizations
10.5.4. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product,
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Bioprocess Analyzers Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Instruments
11.3.2. Consumables & Accessories
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Antibiotics
11.4.2. Recombinant Proteins
11.4.3. Biosimilars
11.4.4. Monoclonal Antibodies
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Biopharmaceutical Companies
11.5.2. Contract Manufacturing Organizations
11.5.3. Contract Research Organizations
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product,
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Bioprocess Analyzers Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Instruments
12.3.2. Consumables & Accessories
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Antibiotics
12.4.2. Recombinant Proteins
12.4.3. Biosimilars
12.4.4. Monoclonal Antibodies
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Biopharmaceutical Companies
12.5.2. Contract Manufacturing Organizations
12.5.3. Contract Research Organizations
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product,
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Bioprocess Analyzers Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Instruments
13.3.2. Consumables & Accessories
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Antibiotics
13.4.2. Recombinant Proteins
13.4.3. Biosimilars
13.4.4. Monoclonal Antibodies
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Biopharmaceutical Companies
13.5.2. Contract Manufacturing Organizations
13.5.3. Contract Research Organizations
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product,
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Bioprocess Analyzers Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Instruments
14.3.2. Consumables & Accessories
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Antibiotics
14.4.2. Recombinant Proteins
14.4.3. Biosimilars
14.4.4. Monoclonal Antibodies
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Biopharmaceutical Companies
14.5.2. Contract Manufacturing Organizations
14.5.3. Contract Research Organizations
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Nova Biomedical
15.3.1.1. Company Overview
15.3.1.2. Technology, Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Sartorius Group
15.3.2.1. Company Overview
15.3.2.2. Technology, Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. F. Hoffmann-La Roche Ltd.
15.3.3.1. Company Overview
15.3.3.2. Technology, Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. SYSBIOTECH GmbH
15.3.4.1. Company Overview
15.3.4.2. Technology, Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Kaiser Optical Systems, Inc.
15.3.5.1. Company Overview
15.3.5.2. Technology, Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. YSI, Inc. (Xylem, Inc.)
15.3.6.1. Company Overview
15.3.6.2. Technology, Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Randox Laboratories Ltd.
15.3.7.1. Company Overview
15.3.7.2. Technology, Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
List of Tables
Table 01: Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Bioprocess Analyzers Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Bioprocess Analyzers Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Bioprocess Analyzers Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Bioprocess Analyzers Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Bioprocess Analyzers Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Bioprocess Analyzers Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Bioprocess Analyzers Market Size (US$ Mn) and Distribution (%), by Region, 2017–2031
Figure 02: Bioprocess Analyzers Market Revenue (US$ Mn), by Product, 2022
Figure 03: Bioprocess Analyzers Market Value Share, by Product, 2022
Figure 04: Bioprocess Analyzers Market Revenue (US$ Mn), by Application, 2022
Figure 05: Bioprocess Analyzers Market Value Share, by Application, 2022
Figure 06: Bioprocess Analyzers Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Bioprocess Analyzers Market Value Share, by End-user, 2022
Figure 08: Bioprocess Analyzers Market Value Share, by Region, 2022
Figure 09: Bioprocess Analyzers Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Bioprocess Analyzers Market Value Share Analysis, by Product, 2017–2031
Figure 11: Bioprocess Analyzers Market Attractiveness Analysis, by Product, 2017–2031
Figure 12: Bioprocess Analyzers Market Value Share Analysis, by Application, 2017–2031
Figure 13: Bioprocess Analyzers Market Attractiveness Analysis, by Application, 2017–2031
Figure 14: Bioprocess Analyzers Market Value Share Analysis, by End-user, 2017–2031
Figure 15: Bioprocess Analyzers Market Attractiveness Analysis, by End-user, 2017–2031
Figure 16: Bioprocess Analyzers Market Value Share Analysis, by Region, 2017–2031
Figure 17: Bioprocess Analyzers Market Attractiveness Analysis, by Region, 2017–2031
Figure 18: North America Bioprocess Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Bioprocess Analyzers Market Attractiveness Analysis, by Country, 2017–2031
Figure 20: North America Bioprocess Analyzers Market Value Share Analysis, by Country, 2017–2031
Figure 21: North America Bioprocess Analyzers Market Value Share Analysis, by Product, 2017–2031
Figure 22: North America Bioprocess Analyzers Market Value Share Analysis, by Application, 2017–2031
Figure 23: North America Bioprocess Analyzers Market Value Share Analysis, by End-user, 2017–2031
Figure 24: North America Bioprocess Analyzers Market Attractiveness Analysis, by Product, 2017–2031
Figure 25: North America Bioprocess Analyzers Market Attractiveness Analysis, by Application, 2017–2031
Figure 26:North America Bioprocess Analyzers Market Attractiveness Analysis, by End-user, 2017–2031
Figure 27: Europe Bioprocess Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Bioprocess Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 29: Europe Bioprocess Analyzers Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 30: Europe Bioprocess Analyzers Market Value Share Analysis, by Product, 2017–2031
Figure 31: Europe Bioprocess Analyzers Market Value Share Analysis, by Application, 2017–2031
Figure 32: Europe Bioprocess Analyzers Market Value Share Analysis, by End-user, 2017–2031
Figure 33: Europe Bioprocess Analyzers Market Attractiveness Analysis, by Product, 2017–2031
Figure 34: Europe Bioprocess Analyzers Market Attractiveness Analysis, by Application, 2017–2031
Figure 35: Europe Bioprocess Analyzers Market Attractiveness Analysis, by End-user, 2017–2031
Figure 36: Asia Pacific Bioprocess Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Bioprocess Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 38: Asia Pacific Bioprocess Analyzers Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 39: Asia Pacific Bioprocess Analyzers Market Value Share Analysis, by Product, 2017–2031
Figure 40: Asia Pacific Bioprocess Analyzers Market Value Share Analysis, by Application, 2017–2031
Figure 41: Asia Pacific Bioprocess Analyzers Market Value Share Analysis, by End-user, 2017–2031
Figure 42: Asia Pacific Bioprocess Analyzers Market Attractiveness Analysis, by Product, 2017–2031
Figure 43: Asia Pacific Bioprocess Analyzers Market Attractiveness Analysis, by Application, 2017–2031
Figure 44: Asia Pacific Bioprocess Analyzers Market Attractiveness Analysis, by End-user, 2017–2031
Figure 45: Latin America Bioprocess Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Bioprocess Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 47: Latin America Bioprocess Analyzers Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 48: Latin America Bioprocess Analyzers Market Value Share Analysis, by Product, 2017–2031
Figure 49: Latin America Bioprocess Analyzers Market Value Share Analysis, by Application, 2017–2031
Figure 50: Latin America Bioprocess Analyzers Market Value Share Analysis, by End-user, 2017–2031
Figure 51: Latin America Bioprocess Analyzers Market Attractiveness Analysis, by Product, 2017–2031
Figure 52: Latin America Bioprocess Analyzers Market Attractiveness Analysis, by Application, 2017–2031
Figure 53: Latin America Bioprocess Analyzers Market Attractiveness Analysis, by End-user, 2017–2031
Figure 54: Middle East & Africa Bioprocess Analyzers Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Bioprocess Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 56: Middle East & Africa Bioprocess Analyzers Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 57: Middle East & Africa Bioprocess Analyzers Market Value Share Analysis, by Product, 2017–2031
Figure 58: Middle East & Africa Bioprocess Analyzers Market Value Share Analysis, by Application, 2017–2031
Figure 59: Middle East & Africa Bioprocess Analyzers Market Value Share Analysis, by End-user, 2017–2031
Figure 60: Middle East & Africa Bioprocess Analyzers Market Attractiveness Analysis, by Product, 2017–2031
Figure 61: Middle East & Africa Bioprocess Analyzers Market Attractiveness Analysis, by Application, 2017–2031
Figure 62: Middle East & Africa Bioprocess Analyzers Market Attractiveness Analysis, by End-user, 2017–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bioprocess Analyzers Market
*86 figures and 60 tables includes